Firm Members
Shrinal Inamdar – VP of Investor Relations
Kenneth Galbraith – Chairman of the Board, CEO & President
Kristin Stafford – Govt VP & CFO
Paul Moore – Chief Scientific Officer
Sabeen Mekan – SVP & Chief Medical Officer
Adam Schayowitz – Govt VP and Head of Analysis & Growth
Convention Name Members
Eva Fortea-Verdejo – Wells Fargo Securities, LLC, Analysis Division
Yue-Wen Zhu – LifeSci Capital, LLC, Analysis Division
Jonathan Miller – Evercore ISI Institutional Equities, Analysis Division
Yigal Nochomovitz – Citigroup Inc. Change Analysis
Mayank Mamtani – B. Riley Securities, Inc., Analysis Division
Reni Benjamin – Residents JMP Securities, LLC, Analysis Division
Stephen Willey – Stifel, Nicolaus & Firm, Integrated, Analysis Division
Yaron Werber – TD Cowen, Analysis Division
Lut Ming Cheng – JPMorgan Chase & Co, Analysis Division
Presentation
Operator
Good day, and thanks for standing by. Welcome to Zymeworks First Quarter 2026 Outcomes Convention Name. [Operator Instructions] Please be suggested that right this moment’s convention is being recorded. I might now like at hand the convention over to your first speaker right this moment, Shrinal Inamdar, VP of Investor Relations. Your line is open.
Shrinal Inamdar
VP of Investor Relations
Thanks, operator. Good afternoon, everybody, and thanks for becoming a member of our first quarter 2026 outcomes convention name. As typical, I would wish to remind you that we’ll be making quite a lot of forward-looking statements throughout this name, together with, with out limitation, these forward-looking statements recognized in our slides and the accompanying oral commentary. These forward-looking statements are based mostly upon our present expectations and varied assumptions and are topic to the dangers and uncertainties, together with these related to corporations in our trade and at our stage of improvement. For a dialogue of those dangers and uncertainties, we refer you to our newest SEC filings as discovered on our web site and as filed with the SEC.
